52 Week Range
As of on the Stockholm Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Essity Raises EUR 300 Mln In Bond Market
Essity expects to increase CAPEX to 7.5 bln SEK in 2020
Essity Q3 Adjusted EBITA Sek 4.18 Billion
Essity AB (publ) is a Sweden-based hygiene and health company that develops, produces, markets and sells personal care and tissue products. The Company conducts sales in about 150 countries under such brands, as TENA for incontinence products and Tork for Away-from-Home tissue, as well as under other brands, such as Bodyform, Velvet, Cushelle and Plenty. The Company’s medical brands comprise Leukoplast, Cutimed, JOBST, Delta Cast, Delta Lite and Actimove.
Chairman of the Board
President, Chief Executive Officer, Director
Executive Vice President and Chief Financial Officer, Head of Group Function Finance
Senior Vice President, Group Function Legal Affairs, General Counsel, Secretary of the Board
Anna Savinger Aslund
Senior Vice President, Group Function Human Resources
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Swedish hygiene products group Essity posted a bigger than expected rise in fourth-quarter core profit on Thursday as sales of higher priced products and growth in emerging markets helped it to offset rising pulp costs.
Hygiene products group Essity posted on Thursday a bigger rise than expected in fourth-quarter core profit despite higher pulp costs, helped by emerging market growth and recently acquired medical equipment firm BSN Medical.
Hygiene products group Essity posted on Thursday a slightly bigger than expected rise in quarterly core profit and returned to comparable sales growth despite a jump in raw material costs, sending its shares higher.
Swedish hygiene products firm Essity , which was spun off from SCA in June, posted on Tuesday a bigger than expected rise in second-quarter core earnings and said like-for-like sales were flat in a challenging market.
* Allocation of acquisition cost for shares in connection with SCA's distribution of the shares in Essity
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.